Detalhe da pesquisa
1.
Superior immunogenicity and effectiveness of the third compared to the second BNT162b2 vaccine dose.
Nat Immunol
; 23(6): 940-946, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35534723
2.
Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months.
N Engl J Med
; 385(24): e84, 2021 12 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34614326
3.
The Association Between Prebooster Vaccination Antibody Levels and the Risk of Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
Clin Infect Dis
; 76(7): 1315-1317, 2023 04 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36366729
4.
Cocirculation of A(H3N2) and B/Victoria increased morbidity in hospitalized patients in the 2019-2020 A(H1N1)pdm09 predominant influenza season in Israel.
J Med Virol
; 95(2): e28498, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36653733
5.
Early Immunogenicity and Safety of the Third Dose of BNT162b2 Messenger RNA Coronavirus Disease 2019 Vaccine Among Adults Older Than 60 Years: Real-World Experience.
J Infect Dis
; 225(5): 785-792, 2022 03 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34850049
6.
Existence of immunological memory response in true sero-negative individuals post COVID-19 molecular diagnosis.
Clin Infect Dis
; 2022 Mar 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35271690
7.
Omicron BA.2.75 variant is efficiently neutralised following BA.1 and BA.5 breakthrough infection in vaccinated individuals, Israel, June to September 2022.
Euro Surveill
; 27(44)2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36330820
8.
COVID-19 vaccination and BA.1 breakthrough infection induce neutralising antibodies which are less efficient against BA.4 and BA.5 Omicron variants, Israel, March to June 2022.
Euro Surveill
; 27(30)2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35904058
9.
The impact of SARS-CoV-2 on respiratory syndromic and sentinel surveillance in Israel, 2020: a new perspective on established systems.
Euro Surveill
; 27(16)2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35451365
10.
Comparing immunogenicity and efficacy of two different mRNA-based COVID-19 vaccines as a fourth dose; six-month follow-up, Israel, 27 December 2021 to 24 July 2022.
Euro Surveill
; 27(39)2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36177870
11.
Emergence of genetically linked vaccine-originated poliovirus type 2 in the absence of oral polio vaccine, Jerusalem, April to July 2022.
Euro Surveill
; 27(37)2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36111556
12.
The Solution Is a Solution.
Isr Med Assoc J
; 24(2): 80-84, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-35187895
13.
Sensitive Immunodetection of Severe Acute Respiratory Syndrome Coronavirus 2 Variants of Concern 501Y.V2 and 501Y.V1.
J Infect Dis
; 224(4): 616-619, 2021 08 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-34398244
14.
SARS-CoV-2 outbreak in a synagogue community: longevity and strength of anti-SARS-CoV-2 IgG responses.
Epidemiol Infect
; 149: e153, 2021 06 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34372950
15.
Under-diagnosis of SARS-CoV-2 infections among children aged 0-15 years, a nationwide seroprevalence study, Israel, January 2020 to March 2021.
Euro Surveill
; 26(48)2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34857069
16.
Immunoglobulin (Ig)A seropositivity against SARS-CoV-2 in healthcare workers in Israel, 4 April to 13 July 2020: an observational study.
Euro Surveill
; 26(48)2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34857065
17.
Neutralising capacity against Delta (B.1.617.2) and other variants of concern following Comirnaty (BNT162b2, BioNTech/Pfizer) vaccination in health care workers, Israel.
Euro Surveill
; 26(26)2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34212838
18.
Lessons from intensified surveillance of viral hepatitis A, Israel, 2017 and 2018.
Euro Surveill
; 26(6)2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33573709
19.
The SARS-CoV-2 Lambda variant and its neutralisation efficiency following vaccination with Comirnaty, Israel, April to June 2021.
Euro Surveill
; 26(45)2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34763751
20.
Six-Month Follow-up after a Fourth BNT162b2 Vaccine Dose.
N Engl J Med
; 387(22): 2092-2094, 2022 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36351266